Dr Reddy’s relaunch OTC Famotidine Tablets USP, 10 mg and 20 mg, in US
They are acid reducers that prevent and relieve heartburn associated with acid indigestion and sour stomach brought on by eating…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India
The Indian regulator has instructed Dr Reddy’s Laboratories carry out the trials of the vaccine with proper monitoring of immune…
DRL joins SBTi and sets 2030 GHG emission targets
The company is the first Indian and the third Asian pharmaceutical company to have set its Science-Based Targets to further…
Dr Reddy’s launches generic sapropterin dihydrochloride tablets for oral use in US
They are indicated to reduce blood phenylalanine levels in adult and paediatric patients with hyperphenylalaninemia due to…
Dr Reddy’s seeks DCGI approval for Phase 3 clinical trials of Sputnik V in India
The Indian pharma company has partnered with RDIF to conduct clinical trials Russian COVID-19 vaccine
Dr Reddy’s launches Cinacalcet Tablets in US
They are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30
Dr Reddy’s launches dimethyl fumarate DR capsules in US
It is a therapeutic equivalent generic version of Tecfidera
Dr Reddy’s launches dexmedetomidine hydrochloride in 0.9% sodium chloride injection in US
It is an alpha-adrenergic agonist indicated for sedation of initially intubated and mechanically ventilated patients during…
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US
Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…
Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US
They are indicated for the temporary relief of eye allergies like itchy eyes due to pollen, ragweed, grass, animal hair and dander